2005 | Impaired nonhomologous end-joining in mismatch repair-deficient colon carcinomas
| LABORATORY INVESTIGATION |
2005 | ADP-overexpressing adenovirus elicits enhanced cytopathic effect by induction of apoptosis | CANCER GENE THERAPY |
2005 | Coxsackie and adenovirus receptor binding ablation reduces adenovirus liver tropism and toxicity | HUMAN GENE THERAPY |
2005 | E1A/E1B 이중변이형 종양 선택적 살상 아데노바이러스의 개선된 암세포 살상 효과 및 항종양 효과
| Journal of Bacteriology and Virology |
2005 | Correlation of KIT and platelet-derived growth factor receptor α mutations with gene activation and expression profiles in gastrointestinal stromal tumors | ONCOGENE |
2003 | 간암 특이적 복제 가능 아데노바이러스의 개발
| Journal of Bacteriology and Virology |
2003 | Ad-mTERT-Δ19, a Conditional Replication-Competent Adenovirus Driven by the Human Telomerase Promoter, Selectively Replicates in and Elicits Cytopathic Effect in a Cancer Cell-Specific Manner | HUMAN GENE THERAPY |
2003 | Increased Cytopathic Effect of Replicating Adenovirus Expressing Adenovirus Death Protein
| CANCER RESEARCH AND TREATMENT |
2003 | Development of a Conditional Replication Competent Adenovirus, Controlled by the Human Telomerase Promoter
| CANCER RESEARCH AND TREATMENT |
2003 | dl-VSVG-LacZ, a VSV-G epitope incorporated adenoviurs exhibit marked enhancement in gene transduction efficiency | HUMAN GENE THERAPY |
2002 | Antitumoral effects of recombinant adenovirus YKL-1001, conditionally replicating in α-fetoprotine-producing human liver cancer cells | CANCER LETTERS |
2002 | Evaluation of E1b gene-attenuated replicating adenoviruses for cancer gene therapy
| CANCER GENE THERAPY |
2001 | Predominant role of endothelial nitric oxide synthase in VEGF-induced angiogenesis and vascular permeability
| PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA |
2001 | Efficient gene transfer of VSV-G pseudotyped retroviral vector to human brain tumor
| GENE THERAPY |
2001 | Vascular Endothelial Growth Factor (VEGF)-C Differentially Affects Tumor Vascular Function and Leukocyte Recruitment: Role of VEGF-Receptor 2 and Host VEGF-A 1
| CANCER RESEARCH |
2001 | Evaluation of E1B - mutant Replicating Adenoviruses for Cancer Gene Therapy
| CANCER RESEARCH AND TREATMENT |
2000 | Targeting of T lymphocytes to melanoma cells through chimeric anti-GD3 immunoglobulin T-cell receptors
| Neoplasia |
2000 | Oncolytic potential of E1B 55 kDa‐deleted YKL‐1 recombinant adenovirus: Correlation with p53 functional status
| International Journal of Cancer |